Macrocyclolux

Gadoteric acid, the active ingredient in Macrocyclolux, is a gadolinium‑based contrast agent presented as an injection solution for intravenous use. It enhances magnetic resonance imaging by increasing signal intensity, aiding diagnosis of brain, spine, liver and vascular conditions in patients undergoing MRI examinations.

GNH USA supplies Macrocyclolux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and imaging centres worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand through reliable cold‑chain logistics.

Macrocyclolux, a gadolinium‑based contrast agent, is employed in magnetic resonance imaging to improve visualization of specific anatomical regions.

Brain MRI: provides enhanced signal intensity that facilitates detection of intracranial lesions and vascular abnormalities. Spine MRI: improves contrast of spinal cord, vertebral bodies and surrounding soft tissues for better assessment of pathology. Liver MRI: enables clearer delineation of focal liver lesions and vascular structures during hepatic imaging. MRI angiography: enhances vascular delineation, allowing detailed evaluation of arterial and venous anatomy.

Adverse reactions to Macrocyclolux may vary in frequency and severity.

Common Side Effects: - Nausea - Headache - Injection site warmth or flushing - Metallic taste in the mouth

Serious or Rare Side Effects: - Nephrogenic systemic fibrosis (NSF) - Severe allergic reaction or anaphylaxis - Cardiovascular collapse or severe hypotension

Prior to administration, several safety considerations should be observed.

Renal function assessment: evaluate kidney function before administration. Hydration status: ensure adequate patient hydration to reduce renal risk. Prior contrast reactions: review history of hypersensitivity to gadolinium agents. Pregnancy: use only if clearly needed, as safety data are limited. Concomitant nephrotoxic drugs: avoid or monitor closely. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Macrocyclolux may interact with other agents, requiring careful management.

Major Interactions (Avoid): - Concurrent use of other gadolinium‑based contrast agents: cumulative gadolinium exposure may increase toxicity risk. - Ferumoxytol (iron oxide nanoparticle): can cause diagnostic interference and potential adverse reactions.

Moderate Interactions (Monitor Closely): - Loop diuretics: may affect renal clearance of gadolinium, requiring monitoring of kidney function. - ACE inhibitors or ARBs: may influence renal perfusion; monitor renal parameters during and after administration.